Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces Powerful Enhancements to Leading Life Science Software
Friday, October 31, 2014
New GeneSpring platform enables faster discovery of complex relationships across multi-omic data.

Pexip® Releases Infinity Version 7
Friday, October 31, 2014
New version of scalable meeting platform enhances Lync® functionality, adds infinity connect client software, and improves accessibility.

Nagoya University’s ITbM, Japan, Licenses Cresset’s Forge
Thursday, October 30, 2014
ITbM licenses Cresset’s computational chemistry software to accelerate their research.

Spectral Surface Mapping with Microscopic Resolution
Thursday, October 30, 2014
S2M™ software gives users the ability to map the Raman and UV-visible-NIR absorbance, reflectance or fluorescence spectral response, point-by-point, with microscopic spatial resolution.

Biognosys’ Spectronaut™ Software Now Supports Thermo Scientific™ Proteome Discoverer™ Platform
Monday, October 27, 2014
Proteome Discoverer™ users can generate spectral libraries with Spectronaut™ software.

HORIBA Releases LabSpec 6 MultiWell for Raman
Friday, October 24, 2014
High Throughput Screening for Raman chemical analyzers.

BioDiscovery Launches NxClinical™ Software
Wednesday, October 22, 2014
A unique solution for complete case review and reporting for genetics labs.

Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

DNASTAR Releases Lasergene 12.1 Software
Saturday, October 11, 2014
Lasergene 12.1 integrates cloud capability with ground computers.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 871
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv